vs
Side-by-side financial comparison of DULUTH HOLDINGS INC. (DLTH) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $114.9M, roughly 1.6× DULUTH HOLDINGS INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -8.8%, a 9.7% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -9.6%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-8.9M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -31.6%).
Duluth Holdings Inc., which primarily sells goods through its Duluth Trading Company brand, is an American workwear and accessories company.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
DLTH vs FOLD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $114.9M | $185.2M |
| Net Profit | $-10.1M | $1.7M |
| Gross Margin | 53.8% | 85.7% |
| Operating Margin | -7.7% | 8.6% |
| Net Margin | -8.8% | 0.9% |
| Revenue YoY | -9.6% | 23.7% |
| Net Profit YoY | 64.6% | -88.5% |
| EPS (diluted) | $-0.29 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $114.9M | $185.2M | ||
| Q3 25 | $131.7M | $169.1M | ||
| Q2 25 | $102.7M | $154.7M | ||
| Q1 25 | $241.3M | $125.2M | ||
| Q4 24 | $127.1M | $149.7M | ||
| Q3 24 | $141.6M | $141.5M | ||
| Q2 24 | $116.7M | $126.7M | ||
| Q1 24 | $245.6M | $110.4M |
| Q4 25 | $-10.1M | $1.7M | ||
| Q3 25 | $1.3M | $17.3M | ||
| Q2 25 | $-15.3M | $-24.4M | ||
| Q1 25 | $-5.6M | $-21.7M | ||
| Q4 24 | $-28.2M | $14.7M | ||
| Q3 24 | $-2.0M | $-6.7M | ||
| Q2 24 | $-7.9M | $-15.7M | ||
| Q1 24 | $6.4M | $-48.4M |
| Q4 25 | 53.8% | 85.7% | ||
| Q3 25 | 54.7% | 88.5% | ||
| Q2 25 | 52.0% | 90.2% | ||
| Q1 25 | 44.1% | 90.7% | ||
| Q4 24 | 52.3% | 90.1% | ||
| Q3 24 | 52.3% | 90.6% | ||
| Q2 24 | 52.8% | 91.1% | ||
| Q1 24 | 48.2% | 87.7% |
| Q4 25 | -7.7% | 8.6% | ||
| Q3 25 | 1.8% | 20.3% | ||
| Q2 25 | -12.0% | -6.1% | ||
| Q1 25 | -1.8% | -6.3% | ||
| Q4 24 | -17.4% | 10.7% | ||
| Q3 24 | -1.1% | 15.3% | ||
| Q2 24 | -7.7% | 11.8% | ||
| Q1 24 | 3.6% | -25.1% |
| Q4 25 | -8.8% | 0.9% | ||
| Q3 25 | 1.0% | 10.2% | ||
| Q2 25 | -14.9% | -15.8% | ||
| Q1 25 | -2.3% | -17.3% | ||
| Q4 24 | -22.2% | 9.8% | ||
| Q3 24 | -1.4% | -4.8% | ||
| Q2 24 | -6.7% | -12.4% | ||
| Q1 24 | 2.6% | -43.9% |
| Q4 25 | $-0.29 | $0.00 | ||
| Q3 25 | $0.04 | $0.06 | ||
| Q2 25 | $-0.45 | $-0.08 | ||
| Q1 25 | $-0.17 | $-0.07 | ||
| Q4 24 | $-0.84 | $0.05 | ||
| Q3 24 | $-0.06 | $-0.02 | ||
| Q2 24 | $-0.24 | $-0.05 | ||
| Q1 24 | $0.20 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.2M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $160.6M | $274.2M |
| Total Assets | $468.0M | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $293.5M | ||
| Q3 25 | $5.7M | $263.8M | ||
| Q2 25 | $8.6M | $231.0M | ||
| Q1 25 | $3.3M | $250.6M | ||
| Q4 24 | $9.3M | $249.9M | ||
| Q3 24 | $9.8M | $249.8M | ||
| Q2 24 | $6.8M | $260.1M | ||
| Q1 24 | $32.2M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $160.6M | $274.2M | ||
| Q3 25 | $170.0M | $230.4M | ||
| Q2 25 | $167.9M | $204.3M | ||
| Q1 25 | $182.7M | $193.6M | ||
| Q4 24 | $188.1M | $194.0M | ||
| Q3 24 | $215.7M | $178.8M | ||
| Q2 24 | $218.4M | $132.5M | ||
| Q1 24 | $222.8M | $130.7M |
| Q4 25 | $468.0M | $949.9M | ||
| Q3 25 | $433.8M | $868.8M | ||
| Q2 25 | $463.7M | $815.3M | ||
| Q1 25 | $452.4M | $789.8M | ||
| Q4 24 | $533.1M | $785.0M | ||
| Q3 24 | $488.6M | $786.6M | ||
| Q2 24 | $471.4M | $749.5M | ||
| Q1 24 | $491.2M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.7M | $16.3M |
| Free Cash FlowOCF − Capex | $-8.9M | $16.0M |
| FCF MarginFCF / Revenue | -7.8% | 8.6% |
| Capex IntensityCapex / Revenue | 2.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $1.7M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.7M | $16.3M | ||
| Q3 25 | $32.0M | $35.7M | ||
| Q2 25 | $-56.5M | $-26.5M | ||
| Q1 25 | $41.2M | $7.8M | ||
| Q4 24 | $-41.1M | $-3.9M | ||
| Q3 24 | $16.6M | $-23.0M | ||
| Q2 24 | $-33.7M | $22.7M | ||
| Q1 24 | $69.7M | $-29.7M |
| Q4 25 | $-8.9M | $16.0M | ||
| Q3 25 | $29.8M | $35.3M | ||
| Q2 25 | $-57.8M | $-28.9M | ||
| Q1 25 | $38.7M | $7.5M | ||
| Q4 24 | $-43.7M | $-4.2M | ||
| Q3 24 | $15.0M | $-23.3M | ||
| Q2 24 | $-35.2M | $21.6M | ||
| Q1 24 | $60.6M | $-31.5M |
| Q4 25 | -7.8% | 8.6% | ||
| Q3 25 | 22.6% | 20.9% | ||
| Q2 25 | -56.3% | -18.7% | ||
| Q1 25 | 16.0% | 6.0% | ||
| Q4 24 | -34.4% | -2.8% | ||
| Q3 24 | 10.6% | -16.5% | ||
| Q2 24 | -30.2% | 17.0% | ||
| Q1 24 | 24.7% | -28.5% |
| Q4 25 | 2.0% | 0.2% | ||
| Q3 25 | 1.7% | 0.2% | ||
| Q2 25 | 1.3% | 1.6% | ||
| Q1 25 | 1.0% | 0.2% | ||
| Q4 24 | 2.1% | 0.2% | ||
| Q3 24 | 1.2% | 0.3% | ||
| Q2 24 | 1.3% | 0.9% | ||
| Q1 24 | 3.7% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | 25.40× | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLTH
| Sales Channel Directly To Consumer | $67.4M | 59% |
| Sales Channel Through Intermediary | $47.4M | 41% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
